Document is current
Any future updates will be listed below
-
Authors
Gong, Weijing
Xia, Li
Wu, Sanlan
Zhu, Xinxin
Lv, Yongning
Mei, Chao
-
Funding
Funding for this research was provided by:
The National Natural Science Foundation of China (No. 82304634)
The National Natural Science Foundation of China (No.82003868)
Natural Science Foundation of Hubei Province (No. 2023AFD022)
Natural Science Foundation of Hubei Province (2026AFB528)
the Hospital Pharmaceutical Science Research Special Project of the Chinese Pharmaceutical Association (No. CPA-Z05-ZC-2024-002)
the Drug Safety Research Project by Adverse Drug Reactions Journal (ADR2024MS12)
Chinese Pharmaceutical Association Hospital Pharmacy Department (No. CPA-Z05-ZC-2024-003)
- License Information
-
More Information
Article History
Received: 8 July 2026
Accepted: 6 September 2026
First Online: 15 September 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: The authors declare that they have no competing interests.
